Alloimmune T-Cell Responses in Highly Sensitized Kidney Transplant Recipients

Overview

About this study

The purpose of this study is to better understand how the immune system reacts to kidney transplantation in individuals who are potentially at higher risk for rejection.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Kidney transplant candidate with planned transplant.

Exclusion Criteria: 

  • Donor-recipient pair in kidney paired donation.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Carrie Schinstock, M.D.

Open for enrollment

Contact information:

Nong Braaten L.P.N.

(507)538-9617

Braaten.Nong@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Carrie Schinstock, M.D.

Contact us for the latest status

Contact information:

HyeMee Joo Ph.D.

(480)301-9668

Joo.HyeMee@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20439800

Mayo Clinic Footer